Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PNEUMOCELL: Prevenar 13 in IgG Deficiency
NCT01847781Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- May 2013
- Primary completion
- Nov 2013
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal infection, sponsored by Karolinska University Hospital. Started May 2013; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01847781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01847781.